SALMA A TABREZ
Allopathic & Osteopathic Physicians|Family Medicine ORLANDO, FL NPI 1043201643
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine FL Amgen Inc. All categories
General Payments — all program years on this page
$1,306.03
- Category: General Payments
- Program years: PY2018–2024
- Record count: 55
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $194.14 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.14 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $59.28 | 3 |
| Novo Nordisk AS | $44.84 | 2 |
| Abbott Laboratories | $43.58 | 2 |
| Exact Sciences Corporation | $30.08 | 1 |
| Acerta Pharma LLC | $16.36 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096643548 | Novo Nordisk Inc | $22.20 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097618407 | Novo Nordisk Inc | $22.64 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105500888 | AstraZeneca Pharmaceuticals LP | $16.36 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114926558 | Exact Sciences Corporation | $30.08 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116166633 | Amgen Inc. | $22.44 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116166640 | Amgen Inc. | $18.76 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116166647 | Amgen Inc. | $18.08 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124808569 | Abbott Laboratories | $21.51 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124808571 | Abbott Laboratories | $22.07 | 07/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.